Subsequently, genome-wide association studies (GWAS) of patients with JAK2 -V617F-CH and MPN revealed additional associations with germline variants in TERT, SH2B2, TET2, ATM, CHEK2, TINT and GFI1B genes [17]. This evidence concerns the gene JAK2 and myeloproliferative disorder.